Anika Therapeutics Q1 2026 Earnings Massive EPS Beat Defies Expectations SOHON Q2 2025 Earnings Preferred EPS of 021 Reported Stock Edges Lower GBX Q1 2026 Earnings EPS Misses Estimates by Wide Margin Despite Stock Gain Ernexa Therapeutics ERNA Q3 2023 Earnings Net loss of 103 per share highlights ongoing clinical investment stock declines 377 API Q4 2025 Earnings Profitability Emerges Amid Revenue Uncertainty Enlight Renewable Energy Ltd ENLT Q1 2026 Earnings EPS of 008 Reported Stock Gains Amid Sparse Disclosure